PRELUDE CAPITAL MANAGEMENT, LLC - RAPTOR PHARMACEUTICAL CORP ownership

RAPTOR PHARMACEUTICAL CORP's ticker is RPTP and the CUSIP is 75382F106. A total of 95 filers reported holding RAPTOR PHARMACEUTICAL CORP in Q2 2016. The put-call ratio across all filers is 0.29 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of RAPTOR PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2016$1,542,000
+1876.9%
171,958
+1085.9%
0.16%
+1372.7%
Q2 2016$78,000
+62.5%
14,500
+38.6%
0.01%
+57.1%
Q1 2016$48,000
-14.3%
10,465
-2.2%
0.01%
-22.2%
Q4 2015$56,000
-17.6%
10,700
+148.8%
0.01%
-10.0%
Q2 2015$68,000
+209.1%
4,300
+115.0%
0.01%
+233.3%
Q1 2015$22,000
-12.0%
2,000
-20.0%
0.00%0.0%
Q1 2014$25,000
-57.6%
2,500
-44.3%
0.00%
-66.7%
Q4 2013$59,000
+96.7%
4,492
+125.5%
0.01%
+80.0%
Q3 2013$30,000
-36.2%
1,992
-60.2%
0.01%
-50.0%
Q2 2013$47,0005,0000.01%
Other shareholders
RAPTOR PHARMACEUTICAL CORP shareholders Q2 2016
NameSharesValueWeighting ↓
Parametrica Management Ltd 16,355$244,0003.04%
EAM Investors, LLC 175,761$2,626,0000.52%
Tekla Capital Management LLC 110,000$1,643,0000.18%
Jane Street Holding, LLC 447,456$6,676,0000.08%
A.R.T. Advisors, LLC 95,164$1,419,0000.08%
CREDIT SUISSE AG/ 5,079,886$75,792,0000.08%
NOMURA HOLDINGS INC 736,362$10,936,0000.07%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,000,000$14,920,0000.04%
ROYAL BANK OF CANADA 2,971,616$44,337,0000.03%
LORD, ABBETT & CO. LLC 721,849$10,784,0000.02%
View complete list of RAPTOR PHARMACEUTICAL CORP shareholders